Toronto Dominion Bank
NGNE icon

Toronto Dominion Bank’s Neurogene NGNE Stock Holding History

Toronto Dominion Bank’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4M Hold
681,337
– – 0.02% 476
2026
Q1 		$13.7M Hold
681,337
– – 0.02% 533
2025
Q4 		$14M Hold
681,337
– – 0.02% 541
2025
Q3 		$11.8M Hold
681,337
– – 0.02% 564
2025
Q2 		$10.2M Buy
681,337
+442,076
+185% +$6.94M 0.02% 578
2025
Q1 		$2.8M Buy
+239,261
New +$4.16M 0.01% 846

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Toronto Dominion Bank's NGNE Position: Q2 2026 in Review

Toronto Dominion Bank held its Neurogene (NGNE) position steady in Q2 2026 at 681,337 shares worth $21.4M. The position accounts for 0.02% of the portfolio, ranked #476.

Toronto Dominion Bank first reported a position in NGNE in Q1 2025 and has held it in 6 quarters since. 112 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Toronto Dominion Bank held 681,337 shares of Neurogene worth $21.4M as of Q2 2026.
  • Toronto Dominion Bank left its Neurogene share count unchanged in Q2 2026.
  • Neurogene made up 0.02% of Toronto Dominion Bank's portfolio in Q2 2026, its #476 holding.
  • Toronto Dominion Bank first reported a position in Neurogene in Q1 2025 and has held it in 6 quarters since.
  • 112 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.